seqWell, a Beverly, Mass.-based multiplexed solution for preparing NGS libraries from hundreds to thousands of samples without normalization or additional equipment, closed a $9M Series B financing round.

The round was led by Research Corporation Technologies (RCT), joined by the BroadOak Fund and current investors.

seqWell provides a multiplexed library prep product offerings in growing markets such as high-throughput low-pass and targeted genotyping.

Seqwell also appointed genomics industry pioneer and entrepreneur Paul McEwan as Board Chairman, effective as of January 2020.

Mr. McEwan joins the company having co-founded both Kapa Biosystems and Agencourt Bioscience, and most recently served as Vice President, Lifecycle Leader at Roche Sequencing Solutions. | To read full story, visit https://startuparound.com/read/1579033809.0363364/seqWell-Raises-$9M-in-Series-B-Financing?ref=audio_experience